Europe's rich heritage in pharmaceutical innovation has significantly shaped the global landscape. Yet, recent decades have seen this continent cede its leading position to the U.S. and witness emerging markets like China and India surge ahead. The question now is whether Europe can chart a
In a significant move within the life sciences industry, Cryoport, Inc. and SK pharmteco have announced a strategic partnership focused on advancing cell and gene therapy. This collaboration aims to integrate logistics and manufacturing services for biotechnology and pharmaceutical companies,
Sutro Biopharma Inc. (NASDAQ: STRO) has experienced a dynamic market journey characterized by several key financial metrics, analyst ratings, and insider transactions. This article delves into the company’s recent market performance, aiming to provide investors with a comprehensive understanding of
The global biopharmaceutical contract manufacturing market is anticipated to experience significant growth from 2024 to 2032. This market's expansion is driven by continuous technological innovations, increased research and development (R&D) investments, and strategic collaborations among
KBI Biopharma, a prominent contract development and manufacturing organization (CDMO), encountered a critical issue during a GMP (Good Manufacturing Practice) production run. An unexpected pink discoloration appeared in the cell culture media, a crucial component for biologic drug production. The
The resignation of Mr. Zhou Honghao, an independent non-executive director from Genor Biopharma Holdings Limited, has sparked considerable debate and concern among investors and market watchers. With the effective date of the resignation set for September 18, 2024, there are critical questions to
